使用Portico™瓣膜行经导管主动脉瓣置换术后新发左束支传导阻滞的发生率及新发永久起搏器植入的预测因素
该研究前瞻性分析了198例无既往起搏器的高危患者,使用Portico™瓣膜行经导管主动脉瓣植入术。结果显示30天新发永久起搏器植入率为15.2%,1年为16.7%;新发左束支传导阻滞1年发生率为28.3%,多数在30天内自发消退。既往右束支传导阻滞和主动脉瓣环直径是新发永久起搏器植入的独立预测因素,新发永久起搏器植入与1年全因和心血管死亡率无显著关联。
要点
- Portico瓣膜TAVI术后30天新发永久起搏器植入率为15.2%,1年为16.7%。
- 新发左束支传导阻滞1年发生率为28.3%,30天时61.0%自发消退。
- 既往右束支传导阻滞和主动脉瓣环直径是新发永久起搏器植入的独立预测因素。
核心结论
- Portico TAVI系统1年新发永久起搏器植入率可接受,且未增加患者死亡风险。
- 新发左束支传导阻滞在术中常见,多数事件在30天内自发消退。
- 未发现术中因素能独立预测新发永久起搏器植入。
研究设计与样本
- 前瞻性分析Pre-CE Mark Portico TAVI系统研究中198例无既往起搏器的高危患者,平均年龄83.1±4.7岁,女性占77.3%,平均STS评分5.8%。
- 收集术前、术中及术后的十二导联心电图和超声心动图数据,临床随访1年。
主要发现
- 经股动脉植入Portico瓣膜后30天新发永久起搏器植入率为15.2%,1年为16.7%。
- 187例无既往左束支传导阻滞的患者中,53例(28.3%)在1年内新发左束支传导阻滞,其中23例发生于术中。
- 30天时,新发左束支传导阻滞自发消退率为61.0%。
- 新发左束支传导阻滞与新建永久起搏器植入无关联(P=0.64);53例中8例需要新起搏器。
- 多变量回归分析显示,既往右束支传导阻滞(P=0.004)和主动脉瓣环直径(P=0.001)是新发永久起搏器植入的独立预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the incidence and timing of new-onset left bundle branch block (LBBB) and new permanent pacemaker implantation (PPI) in patients undergoing transcatheter aortic valve implantation (TAVI) using the repositionable, self-expanding Portico™ TAVI system (St. Jude Medical, St Paul, MN, USA). Clinical impact and periprocedural factors associated with new PPI were also assessed. METHODS: A total of 198 high-risk patients without pre-existing pacemaker [83.1 ± 4.7 years, 77.3% women, mean Society of Thoracic Surgeons (STS) 5.8%] from the Pre-CE Mark Portico TAVI system study were prospectively analysed. Twelve-lead electrocardiographic and echocardiographic data were collected prior to, during and after the procedure. Clinical follow-up was performed at 1 year. RESULTS: Transfemoral implantation of the Portico valve was associated with a new PPI rate of 15.2% at 30 days and 16.7% at 1 year. Overall, 53 of the 187 patients without pre-existing LBBB developed new-onset LBBB at 1 year (28.3%); 23 occurred during the procedure. At 30 days, new-onset LBBB spontaneously resolved in 61.0% of patients. New-onset LBBB post-TAVI was not associated with new PPI (P = 0.64); 8 of the 53 patients required new PPI. Multivariable regression analyses revealed pre-existing right bundle branch block (P = 0.004) and aortic annulus diameter (P = 0.001) as independent predictors of new PPI. New PPI at discharge (n = 29) was not associated with increased freedom from all-cause (odds ratio 92.7%, 95% confidence interval 73.7-98.1%; P = 0.49) and cardiovascular (odds ratio 96.6%, 95% confidence interval 77.9-99.5%; P = 0.47) mortality at 1 year. CONCLUSIONS: The Portico TAVI system demonstrated an acceptable rate of new PPI at 1 year without increased mortality risk to patients. New-onset LBBB was common during the procedure, with the majority of events spontaneously resolving by 30 days. No intraprocedural factors were shown to independently predict new PPI. CLINICAL TRIAL REGISTRATION NUMBER: NCT01493284.
引用
- Walther T, Manoharan G, Linke A, et al. Incidence of new-onset left bundle branch block and predictors of new permanent pacemaker following transcatheter aortic valve replacement with the Portico™ valve. Eur J Cardiothorac Surg. 2018. PMID: 29534170. doi:10.1093/ejcts/ezy078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。